From Anthony Hardie, Madison, Wis.
I’ve just gone through the full Defense Committee bill (before yesterday’s markup) and the corresponding report language on the various CDMRP programs. The results are below.
FY12 Defense Appropriations — Full Committee Bill (before yesterday’s markup):
1. Several programs would not be funded at all: most notably the sort of catch-all Peer Reviewed Medical Research Program; Neuro-fibromatosis; Pain Management; Global Deployment of the Force medical research; Armed Forces Institute of Regenerative Medicine; and SBIR to the core funded RDT&E.
2. Two programs with the most direct military relevance would see 25% increased funding: Traumatic Brain Injury and Psychological Health (increased from $100m to $125m); Orthopedic (from $24m to $30m).
3. Three new programs were created: Hemorrhage Control; Restorative Transplantation; and, a Joint War-fighter Medical Research Program — totaling $75m.
4. The other 17 programs funded in FY11 would be continued but cut by 20%. Despite the most direct military relevance, these included Spinal Cord Injury, Vision, Gulf War Illness, and Alcohol and Substance Abuse Disorders.
FY11 appropriations — FY 12 Appropriations Committee Bill Recommended Amounts (before yesterday’s markup)
1. ALS $8,000 — $6,400
2. Armed Forces Institute of Regenerative Medicine $4,800 — -0-
3. Autism Research $6,400 — $5,100
4. Bone Marrow Failure Disease Research Program $4,000 — $3,200
5. Duchenne Muscular Dystrophy $4,000 — $3,200
6. Global HIV/AIDS Prevention $10,000 — $8,000
7. Traumatic Brain Injury and Psychological Health $100,000